Fucoidan inhibits the proliferation of human urinary bladder cancer T24 cells by blocking cell cycle progression and inducing apoptosis

Molecules

Volumn 19, Issue 5, 2014, Pages 5981-5998

  Park, Hye Young ^a   Kim, Gi Young ^b   Moon, Sung Kwon ^c   Kim, Wun Jae ^d   Yoo, Young Hyun ^e   Choi, Yung Hyun ^f  

^a Pusan National University   (South Korea)

^b Jeju National University   (South Korea)

^c Chung Ang University   (South Korea)

^d Chungbuk National University College of Medicine   (South Korea)

^e Dong A University College of Medicine   (South Korea)

^f Dong Eui University   (South Korea)

Author keywords

Apoptosis; Bladder cancer; Caspase; Fucoidan; G1 arrest; P21; TBid

Indexed keywords

CASPASE; FUCOIDIN; POLYSACCHARIDE;

APOPTOSIS; BIOSYNTHESIS; CELL CYCLE CHECKPOINT; CELL PROLIFERATION; DRUG EFFECTS; GENE EXPRESSION REGULATION; HUMAN; METABOLISM; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRION; PATHOLOGY; SIGNAL TRANSDUCTION; TUMOR CELL LINE; URINARY BLADDER NEOPLASMS;

APOPTOSIS; CASPASES; CELL CYCLE CHECKPOINTS; CELL LINE, TUMOR; CELL PROLIFERATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MEMBRANE POTENTIAL, MITOCHONDRIAL; MITOCHONDRIA; POLYSACCHARIDES; SIGNAL TRANSDUCTION; URINARY BLADDER NEOPLASMS;

EID: 84901407734     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules19055981     Document Type: Article

References (45)

1. Sperka, T.; Wang, J.; Rudolph, K.L. DNA damage checkpoints in stem cells, ageing and cancer. Nat. Rev. Mol. Cell Biol. 2012, 13, 579-590.
2. Canavese, M.; Santo, L.; Raje, N. Cyclin dependent kinases in cancer: Potential for therapeutic intervention. Cancer Biol. Ther. 2012, 13, 451-457.
3. Lee, M.H.; Yang, H.Y. Negative regulators of cyclin-dependent kinases and their roles in cancers. Cell Mol. Life Sci. 2001, 58, 1907-1922.
4. Li, A.; Blow, J.J. The origin of CDK regulation. Nat. Cell Biol. 2001, 3, E182-E184.
5. Paternot, S.; Bockstaele, L.; Bisteau, X.; Kooken, H.; Coulonval, K.; Roger, P.P. Rb inactivation in cell cycle and cancer: The puzzle of highly regulated activating phosphorylation of CDK4 versus constitutively active CDK-Activating kinase. Cell Cycle 2010, 9, 689-699.
6. Dobashi, Y.; Takehana, T.; Ooi, A. Perspectives on cancer therapy: Cell cycle blockers and perturbators. Curr. Med. Chem. 2003, 10, 2549-2558.
7. Hensley, P.; Mishra, M.; Kyprianou, N. Targeting caspases in cancer therapeutics. Biol. Chem. 2013, 394, 831-843.
8. MacKenzie, S.H.; Clark, A.C. Targeting cell death in tumors by activating caspases. Curr. Cancer Drug Targets 2008, 8, 98-109.
9. Chung, K.M.; Yu, S.W. Interplay between autophagy and programmed cell death in mammalian neural stem cells. BMB Rep. 2013, 46, 383-390.
10. Brenner, D.; Mak, T.W. Mitochondrial cell death effectors. Curr. Opin. Cell Biol. 2009, 21, 871-877.
11. Jin, Z.; El-Deiry, W.S. Overview of cell death signaling pathways. Cancer Biol. Ther. 2005, 4, 139-163.
12. Fadeel, B.; Orrenius, S. Apoptosis: A basic biological phenomenon with wide-ranging implications in human disease. J. Intern. Med. 2005, 258, 479-517.
13. Mišurcová, L.; Škrovánková, S.; Samek, D.; Ambrožová, J.; Machu, L. Health benefits of algal polysaccharides in human nutrition. Adv. Food Nutr. Res. 2012, 66, 75-145.
14. Kim, S.K.; Li, Y.X. Medicinal benefits of sulfated polysaccharides from sea vegetables. Adv. Food Nutr. Res. 2011, 64, 391-402.
15. Gomez-Gutierrez, C.M.; Guerra-Rivas, G.; Soria-Mercado, I.E.; Ayala-Sánchez, N.E. Marine edible algae as disease preventers. Adv. Food Nutr. Res. 2011, 64, 29-39.
16. Bilan, M.I.; Grachev, A.A.; Ustuzhanina, N.E.; Shashkov, A.S.; Nifantiev, N.E.; Usov, A.I. Structure of a fucoidan from the brown seaweed Fucus. evanescens C. Ag. Carbohydr. Res. 2002, 337, 719-730.
17. Li, B.; Lu, F.; Wei, X.; Zhao, R. Fucoidan: Structure and bioactivity. Molecules 2008, 13, 1671-1695.
18. Wang, W.; Wang, S.X.; Guan, H.S. The antiviral activities and mechanisms of marine polysaccharides: An overview. Mar. Drugs 2012, 10, 2795-2816.
19. Senni, K.; Pereira, J.; Gueniche, F.; Delbarre-Ladrat, C.; Sinquin, C.; Ratiskol, J.; Godeau, G.; Fischer, A.M.; Helley, D.; Colliec-Jouault, S. Marine polysaccharides: A source of bioactive molecules for cell therapy and tissue engineering. Mar. Drugs 2011, 9, 1664-1681.
20. Fitton, J.H. Therapies from fucoidan; multifunctional marine polymers. Mar. Drugs 2011, 9, 1731-1760.
21. Kyung, J.; Kim, D.; Park, D.; Yang, Y.H.; Choi, E.K.; Lee, S.P.; Kim, T.S.; Lee, Y.B.; Kim, Y.B. Synergistic anti-inflammatory effects of Laminaria. japonica fucoidan and Cistanche. tubulosa extract. Lab. Anim. Res. 2012, 28, 91-97.
22. Senthilkumar, K.; Manivasagan, P.; Venkatesan, J.; Kim, S.K. Brown seaweed fucoidan: Biological activity and apoptosis, growth signaling mechanism in cancer. Int. J. Biol. Macromol. 2013, 60, 366-374.
23. Hsu, H.Y.; Lin, T.Y.; Hwang, P.A.; Tseng, L.M.; Chen, R.H.; Tsao, S.M.; Hsu, J. Fucoidan induces changes in the epithelial to mesenchymal transition and decreases metastasis by enhancing ubiquitin-dependent TGFβ receptor degradation in breast cancer. Carcinogenesis 2013, 34, 874-884.
24. Liu, F.; Wang, J.; Chang, A.K.; Liu, B.; Yang, L.; Li, Q.; Wang, P.; Zou, X. Fucoidan extract derived from Undaria. pinnatifida inhibits angiogenesis by human umbilical vein endothelial cells. Phytomedicine 2012, 19, 797-803.
25. Park, H.S.; Hwang, H.J.; Kim, G.Y.; Cha, H.J.; Kim, W.J.; Kim, N.D.; Yoo, Y.H.; Choi, Y.H. Induction of apoptosis by fucoidan in human leukemia U937 cells through activation of p38 MAPK and modulation of Bcl-2 family. Mar. Drugs 2013, 11, 2347-2364.
26. Park, H.S.; Kim, G.Y.; Nam, T.J.; Kim, N.D.; Choi Y.H. Anti-proliferative activity of fucoidan was associated with the induction of apoptosis and autophagy in AGS human gastric cancer cells. J. Food Sci. 2011, 76, T77-T83.
27. Zhang, Z.; Teruya, K.; Eto, H.; Shirahata, S. Fucoidan extract induces apoptosis in MCF-7 cells via a mechanism involving the ROS-dependent JNK activation and mitochondria-mediated pathways. PLoS One 2011, 6, e27441.
28. Zhang, Z.; Teruya, K.; Yoshida, T.; Eto, H.; Shirahata, S. Fucoidan extract enhances the anti-cancer activity of chemotherapeutic agents in MDA-MB-231 and MCF-7 breast cancer cells. Mar. Drugs 2013, 11, 81-98.
29. Xue, M.; Ge, Y.; Zhang, J.; Liu, Y.; Wang, Q.; Hou, L.; Zheng, Z. Fucoidan inhibited 4T1 mouse breast cancer cell growth in vivo and in vitro via downregulation of Wnt/β-catenin signaling. Nutr. Cancer 2013, 65, 460-468.
30. Xue, M.; Ge, Y.; Zhang, J.; Wang, Q.; Hou, L.; Liu, Y.; Sun, L.; Li, Q. Anticancer properties and mechanisms of fucoidan on mouse breast cancer in vitro and in vivo. PLoS One 2012, 7, e43483.
31. Jin, J.O.; Song, M.G.; Kim, Y.N.; Park, J.I.; Kwak, J.Y. The mechanism of fucoidan-induced apoptosis in leukemic cells: Involvement of ERK1/2, JNK, glutathione, and nitric oxide. Mol. Carcinog. 2010, 49, 771-782.
32. Hyun, J.H.; Kim, S.C.; Kang, J.I.; Kim, M.K.; Boo, H.J.; Kwon, J.M.; Koh, Y.S.; Hyun, J.W.; Park, D.B.; Yoo, E.S.; et al. Apoptosis inducing activity of fucoidan in HCT-15 colon carcinoma cells. Biol. Pharm. Bull. 2009, 32, 1760-1764.
33. Yamasaki-Miyamoto, Y.; Yamasaki, M.; Tachibana, H.; Yamada, K. Fucoidan induces apoptosis through activation of caspase-8 on human breast cancer MCF-7 cells. J. Agric. Food Chem. 2009, 57, 8677-8682.
34. Cooper, M.J.; Haluschak, J.J.; Johnson, D.; Schwartz, S.; Morrison, L.J.; Lippa, M.; Hatzivassiliou, G.; Tan, J. p53 mutations in bladder carcinoma cell lines. Oncol. Res. 1994, 6, 569-579.
35. Pei, X.H.; Xiong, Y. Biochemical and cellular mechanisms of mammalian CDK inhibitors: A few unresolved issues. Oncogene 2005, 24, 2787-2795.
36. Riou, D.; Colliec-Jouault, S.; Pinczon du Sel, D.; Bosch, S.; Siavoshian, S.; le Bert, V.; Tomasoni, C.; Sinquin, C.; Durand, P.; Roussakis, C. Antitumor and antiproliferative effects of a fucan extracted from ascophyllum nodosum against a non-small-cell bronchopulmonary carcinoma line. Anticancer Res. 1996, 16, 1213-1218.
37. Aisa, Y.; Miyakawa, Y.; Nakazato, T.; Shibata, H.; Saito, K.; Ikeda, Y.; Kizaki, M. Fucoidan induces apoptosis of human HS-sultan cells accompanied by activation of caspase-3 and down-regulation of ERK pathways. Am. J. Hematol. 2005, 78, 7-14.
38. Li, D.; Tian, Y.; Ma, Y.; Benjamin, T. p150(Sal2) is a p53-independent regulator of p21(WAF1/CIP). Mol. Cell Biol. 2004, 24, 3885-3893.
39. Aguero, M.F.; Facchinetti, M.M.; Sheleg, Z.; Senderowicz, A.M. Phenoxodiol, a novel isoflavone, induces G1 arrest by specific loss in cyclin-dependent kinase 2 activity by p53-independent induction of p21WAF1/CIP1. Cancer Res. 2005, 65, 3364-3373.
40. Khosravi-Far, R.; Esposti, M.D. Death receptor signals to mitochondria. Cancer Biol. Ther. 2004, 3, 1051-1057.
41. Ola, M.S.; Nawaz, M.; Ahsan, H. Role of Bcl-2 family proteins and caspases in the regulation of apoptosis. Mol. Cell Biochem. 2011, 351, 41-58.
42. Danson, S.; Dean, E.; Dive, C.; Ranson, M. IAPs as a target for anticancer therapy. Curr. Cancer Drug Targets 2007, 7, 785-794.
43. De Graaf, A.O.; de Witte, T.; Jansen, J.H. Inhibitor of apoptosis proteins: New therapeutic targets in hematological cancer? Leukemia 2004, 18, 1751-1759.
44. Bubeník, J.; Baresová, M.; Viklický, V.; Jakoubková, J.; Sainerová, H.; Donner, J. Established cell line of urinary bladder carcinoma (T24) containing tumour-specific antigen. Int. J. Cancer 1973, 11, 765-773.
45. Lee, S.J.; Hwang, S.O.; Noh, E.J.; Kim, D.U.; Nam, M.; Kim, J.H.; Nam, J.H.; Hoe, K.L. Transactivation of bad by vorinostat-induced acetylated p53 enhances doxorubicin-induced cytotoxicity in cervical cancer cells. Exp. Mol. Med. 2014, 46, e76.